Related Experiment Video
Updated: Sep 21, 2025
09:41
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Faith E Davies1, Charlotte Pawlyn2,3, Saad Z Usmani4
1Perlmutter Cancer Center, NYU Langone, New York, New York.
Blood Cancer Discovery
|June 2, 2022
Summary
Advances in multiple myeloma treatment have improved survival, but patient outcomes remain varied. Personalized therapy for high-risk multiple myeloma is crucial for better results.
Area of Science:
- Hematology
- Oncology
- Cancer Genetics
Background:
- The treatment landscape for multiple myeloma has undergone significant evolution.
- Increased scientific understanding has led to improved patient survival rates.
- Despite progress, clinical outcome heterogeneity persists, with some patients experiencing poor prognoses.
Purpose of the Study:
- To discuss principles for developing rational and effective therapeutic strategies.
- To address the need for personalized approaches in high-risk multiple myeloma.
- To explore the role of risk stratification in optimizing treatment.
Main Methods:
- Review of current scientific knowledge and treatment advancements.
- Analysis of factors contributing to outcome variability.
- Discussion of clinical and biochemical parameters.
- Examination of tumor-acquired genetic variants for risk stratification.
Main Results:
- Significant improvements in survival have been observed in multiple myeloma.
- Clinical and biochemical parameters, along with genetic variants, predict outcome variability.
- Risk stratification enables a more personalized therapeutic approach.
Conclusions:
- Personalized therapy based on risk stratification is essential for high-risk multiple myeloma.
- Understanding heterogeneity in clinical outcomes is key to improving patient prognosis.
- Rational development of therapeutic approaches can enhance treatment effectiveness.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.2K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
Related Concept Videos
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:21Cancer Survival Analysis
463
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
463